Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis

Thomas Harder1, Katharina Roepke, Natasha Diller

  • 1Clinic of Obstetrics, Division of Experimental Obstetrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Insights

High birth weight and increased early weight gain are significant risk factors for developing type 1 diabetes. This systematic review and meta-analysis highlights the importance of monitoring infant growth for diabetes prevention strategies.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Epidemiology

Background:

  • Previous research indicates a potential link between early life growth patterns and the subsequent risk of type 1 diabetes.
  • Understanding these associations is crucial for identifying individuals at higher risk and developing targeted interventions.

Purpose of the Study:

  • To systematically review and meta-analyze existing studies on the association between birth weight, weight gain in the first year of life, and the risk of type 1 diabetes.

Main Methods:

  • A systematic review and meta-analysis was conducted, pooling data from twelve studies comprising over 2.3 million individuals.
  • Odds ratios and 95% confidence intervals were calculated for type 1 diabetes risk associated with birth weight and early life weight gain.

Main Results:

  • High birth weight (over 4,000g) was significantly associated with an increased risk of type 1 diabetes (OR=1.17, 95% CI: 1.09, 1.26).
  • Each 1,000g increase in birth weight correlated with a 7% rise in type 1 diabetes risk.
  • Increased weight gain during the first year of life was consistently observed in individuals who developed type 1 diabetes compared to controls.

Conclusions:

  • High birth weight and accelerated weight gain in infancy are identified as significant risk factors for type 1 diabetes.
  • These findings underscore the importance of early life growth parameters in diabetes etiology and prevention.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...